Metastatic potential is determined early in synovial sarcoma development and reflected by tumor molecular features-Reference-Cited by-同舟云学术

Metastatic potential is determined early in synovial sarcoma development and reflected by tumor molecular features

Published:2014-08 Issue: Volume:53 Page:505-513
ISSN:1357-2725
Container-title:The International Journal of Biochemistry & Cell Biology
language:en
Short-container-title:The International Journal of Biochemistry & Cell Biology

Author:

Przybyl Joanna,Sciot Raf,Wozniak Agnieszka,Schöffski Patrick,Vanspauwen Vanessa,Samson Ignace,Siedlecki Janusz A.,Rutkowski Piotr,Debiec-Rychter Maria

Funder

European Union Regional Development Fund

KU Leuven and the Polish National Science Center (NCN)

Publisher

Elsevier BV

Subject

Cell Biology,Biochemistry

Reference35 articles.

1. Evaluation of paediatric osteosarcomas by classic cytogenetic and CGH analyses;Batanian;Mol Pathol,2002

2. A homologue of Drosophila aurora kinase is oncogenic and amplified in human colorectal cancers;Bischoff;EMBO J,1998

3. Clinical experience with aurora kinase inhibitors: a review;Boss;Oncologist,2009

4. Cancer Research UK, www.cancerresearchuk.org/cancer-info/cancerstats/types/soft-tissue-sarcoma/incidence/, accessed in December 2013.

5. Validated prediction of clinical outcome in sarcomas and multiple types of cancer on the basis of a gene expression signature related to genome complexity;Chibon;Nat Med,2010

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Molecular Profiling Defines Three Subtypes of Synovial Sarcoma;Advanced Science;2024-09-10

2. Primary pelvic synovial sarcoma: case report and review of the literature;2023-01-23

3. Integrative multi-omics analysis reveals molecular subtypes and tumor evolution of synovial sarcoma;2022-05-10

4. The Proliferation of Glioblastoma Is Contributed to Kinesin Family Member 18A and Medical Data Analysis of GBM;Frontiers in Genetics;2022-04-08

5. KIF18A is a potential prognostic factor and promotes tumor progression in oral tongue squamous cell carcinoma;BIOCELL;2022